Company profile
NXI Therapeutics
Biotech & Aging Science Companies · Basel, Switzerland
About the company
[Confidence Level: High] NXI Therapeutics is a Basel-based biotechnology organization developing selective immunosuppressants that target the Coronin 1 signaling pathway to treat autoimmune diseases and organ transplant rejection.16
Official links
Explore the full company profile
Explore company Access the complete profile and structured research in the Explorer with eligible account access.